I-Flow
This article was originally published in The Gray Sheet
Executive Summary
Registers up to 6.4 mil. shares for sale with the Securities and Exchange Commission. The offering would include up to 6 mil. shares of common stock owned, or to be owned, by selling shareholders and 393,939 shares issuable upon the exercise of certain warrants. The Irvine, California infusion system manufacturer would only receive proceeds from the sale of common stock issuable upon exercise of the warrants; such proceeds would be used for "working capital and general corporate purposes".